Page last updated: 2024-08-23

nitrosobis(2-oxopropyl)amine and loxiglumide

nitrosobis(2-oxopropyl)amine has been researched along with loxiglumide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, N; Saito, Y; Tomioka, M; Yamamoto, M1
Itho, M; Matsuda, S; Ogura, Y; Sasaki, H; Shimomura, M; Tanigawa, K1

Other Studies

2 other study(ies) available for nitrosobis(2-oxopropyl)amine and loxiglumide

ArticleYear
[Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1993, Volume: 90, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Cricetinae; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Proglumide; Tegafur; Uracil

1993
Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
    World journal of surgery, 2002, Volume: 26, Issue:3

    Topics: Adenocarcinoma, Papillary; Animals; Autoradiography; Biliary Tract Neoplasms; Carcinogens; Cholecystectomy, Laparoscopic; Cricetinae; Disease Models, Animal; Duodenostomy; Female; Hormone Antagonists; Mesocricetus; Nitrosamines; Proglumide; Radiography; Receptors, Cholecystokinin

2002